William Blair initiated coverage of Lantheus with an Outperform rating.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LNTH:
- Lantheus price target lowered to $110 from $125 at Truist
- Truist med tech/biotech analysts hold analyst/industry conference call
- Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting
- Lantheus announces agreement to sell RELISTOR royalties to HealthCare Royalty
- Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty